News
Health agency warns of link between pregnancy complications and weight loss drugs
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, Zepbound, and Mounjaro. A UK health agency warns that these drugs could lead to unintended pregnancies and complications during pregnancy.
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Zepbound was found to be more effective. Study participants using tirzepatide lost more weight after 72 weeks (average loss of 20.2% compared to 13.7% for semaglutide). This translates to an ...
More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
Barchart on MSN5d
Eli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback